Meeting
2018 Genitourinary Cancers Symposium
Analysis of an online tool to explore evolving practice patterns in renal cell carcinoma (RCC).
Authors
Won Kim
University of California San Francisco, San Francisco, CA
Won Kim , Kristen Rosenthal , Thomas E. Hutson , Robert J. Motzer , Elizabeth R. Plimack , Kevin Obholz , Angelique Vinther , Brian I. Rini
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 674)
DOI
10.1200/JCO.2018.36.6_suppl.674
Abstract #
674
Poster Bd #
K3
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Real-world assessment of changing treatment patterns and sequence for patients with metastatic renal cell carcinoma (mRCC) in the first-line (1L) setting.
First Author: Neil J. Shah
Poster
2021 Genitourinary Cancers Symposium
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases.
First Author: İzzet Dogan
Poster
2019 ASCO Annual Meeting
Clinical and economic outcomes associated with sequential treatment in patients with advanced renal cell carcinoma (aRCC).
First Author: Meredith M. Regan
Poster
2019 Genitourinary Cancers Symposium
Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors.
First Author: Amishi Yogesh Shah